Heart doctors get quarterly email nudges to improve prescribing
NCT ID NCT07283666
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether sending cardiologists regular emails about quality goals helps them prescribe recommended medications for heart failure and atrial fibrillation. Researchers will track prescribing rates for 7,000 patients. The goal is to see if simple feedback can improve care without new drugs or procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that simple audit and feedback helps doctors prescribe better, potentially improving care for many heart patients.
- What could go wrong
- This is an observational quality improvement study, not a treatment trial. It may not change prescribing habits or patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could continuing a common heart drug before surgery save lives?
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Could a natural chemical be the key to safer heart failure treatment?
- Could a new injection tame atrial fibrillation?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Can a cholesterol drug keep atrial fibrillation at bay after ablation?